Surgical management of pulmonary atresia with ventricular septal defect: early total correction versus shunt

Jae Gun Kwak1, Chang-Ha Lee, Cheul Lee

  • 1Department of Thoracic and Cardiovascular Surgery, Sejong General Hospital, Bucheon, Gyeonggi Do, Republic of Korea.

Insights

Early total correction for pulmonary atresia with ventricular septal defect is acceptable, avoiding interstage deaths and reducing reoperations, despite a challenging postoperative course. Overall survival rates were similar to shunt operations.

Area of Science:

  • Pediatric Cardiac Surgery
  • Congenital Heart Defects
  • Surgical Outcomes Research

Background:

  • Surgical strategy for pulmonary atresia with ventricular septal defect shifted from shunt operation to early total correction in 2004.
  • This study compares surgical outcomes between shunt and early total correction strategies.

Purpose of the Study:

  • To compare the surgical outcomes of palliative shunt operations versus early total correction in patients with pulmonary atresia with ventricular septal defect.
  • To evaluate mortality, reoperation rates, and postoperative recovery between the two surgical approaches.

Main Methods:

  • Retrospective study of 47 patients with pulmonary atresia with ventricular septal defect (no major aortopulmonary collateral arteries) from 1997-2008.
  • Patients were divided into two groups: 29 undergoing palliative shunt (group S) and 18 undergoing early total correction (group T).
  • Group T patients were significantly younger at surgery (23.2 days) compared to group S (40.1 days).

Main Results:

  • Overall survival rates were similar between groups (p=0.3).
  • Group S had higher reoperation rates (p<0.0001), while group T had higher reintervention rates (p=0.006).
  • Group T experienced longer ventilator support time (p=0.016), but avoided interstage deaths seen in group S.

Conclusions:

  • Early total correction for pulmonary atresia with ventricular septal defect yields acceptable midterm results.
  • While associated with a more complex postoperative course and higher reintervention rates, early total correction eliminates interstage mortality and reduces reoperation needs compared to shunt procedures.
  • The shift in surgical strategy demonstrates a viable alternative with comparable overall survival to traditional shunt operations.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...